Hologic ships 25th Selenia
Production of full-field digital mammography systems is hitting its stride at Hologic. The company has shipped its 25th Lorad Selenia FFDM to the University of Southern California/Norris Comprehensive Cancer Center in Los Angeles. Selenia will serve in
Production of full-field digital mammography systems is hitting its stride at Hologic. The company has shipped its 25th Lorad Selenia FFDM to the University of Southern California/Norris Comprehensive Cancer Center in Los Angeles. Selenia will serve in the Lee Breast Center, a sector of the facility designed exclusively for the detection and treatment of breast diseases. The system is built on the M-IV mammography platform and includes the company's DirectRay flat-panel detector, which converts x-rays to light using amorphous selenium.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
